Brief Report: External Beam Radiation Therapy for the Treatment of Human Pluripotent Stem Cell‐Derived Teratomas

Human pluripotent stem cells, including human embryonic stem cells (hESCs) and human induced PSCs (hiPSCs), have great potential as an unlimited donor source for cell‐based therapeutics. The risk of teratoma formation from residual undifferentiated cells, however, remains a critical barrier to the clinical application of these cells. Herein, we describe external beam radiation therapy (EBRT) as an attractive option for the treatment of this iatrogenic growth. We present evidence that EBRT is effective in arresting growth of hESC‐derived teratomas in vivo at day 28 post‐implantation by using a microCT irradiator capable of targeted treatment in small animals. Within several days of irradiation, teratomas derived from injection of undifferentiated hESCs and hiPSCs demonstrated complete growth arrest lasting several months. In addition, EBRT reduced reseeding potential of teratoma cells during serial transplantation experiments, requiring irradiated teratomas to be seeded at 1 × 103 higher doses to form new teratomas. We demonstrate that irradiation induces teratoma cell apoptosis, senescence, and growth arrest, similar to established radiobiology mechanisms. Taken together, these results provide proof of concept for the use of EBRT in the treatment of existing teratomas and highlight a strategy to increase the safety of stem cell‐based therapies. Stem Cells 2017;35:1994–2000

[1]  Ajay E. Kuriyan,et al.  Vision Loss after Intravitreal Injection of Autologous "Stem Cells" for AMD. , 2017, The New England journal of medicine.

[2]  K. Ligon,et al.  Glioproliferative Lesion of the Spinal Cord as a Complication of "Stem-Cell Tourism". , 2016, The New England journal of medicine.

[3]  A. Trounson,et al.  Pluripotent stem cells progressing to the clinic , 2016, Nature Reviews Molecular Cell Biology.

[4]  A. Connolly,et al.  Comparison of Magnetic Resonance Imaging and Serum Biomarkers for Detection of Human Pluripotent Stem Cell-Derived Teratomas , 2016, Stem cell reports.

[5]  Larry A Couture,et al.  Hurdles to clinical translation of human induced pluripotent stem cells. , 2015, The Journal of clinical investigation.

[6]  G. Lahav,et al.  Stem cells: balancing resistance and sensitivity to DNA damage. , 2014, Trends in cell biology.

[7]  S-J Chiu,et al.  Radiation induces senescence and a bystander effect through metabolic alterations , 2014, Cell Death and Disease.

[8]  S. Moon,et al.  Inhibition of pluripotent stem cell-derived teratoma formation by small molecules , 2013, Proceedings of the National Academy of Sciences.

[9]  I. Weissman,et al.  Tumorigenicity as a clinical hurdle for pluripotent stem cell therapies , 2013, Nature Medicine.

[10]  P. Wu,et al.  Accelerated cellular senescence in solid tumor therapy. , 2012, Experimental oncology.

[11]  D. Sahoo,et al.  An antibody against SSEA-5 glycan on human pluripotent stem cells enables removal of teratoma-forming cells , 2011, Nature Biotechnology.

[12]  Paul J Keall,et al.  Development of a micro-computed tomography-based image-guided conformal radiotherapy system for small animals. , 2010, International journal of radiation oncology, biology, physics.

[13]  Wendy Y. Zhang,et al.  Effects of ionizing radiation on self-renewal and pluripotency of human embryonic stem cells. , 2010, Cancer research.

[14]  Torgny Stigbrand,et al.  Radiation-induced cell death mechanisms , 2010, Tumor Biology.

[15]  Joseph C. Wu,et al.  Long term non-invasive imaging of embryonic stem cells using reporter genes , 2009, Nature Protocols.

[16]  Moustapha Kassem,et al.  Teratoma formation by human embryonic stem cells is site dependent and enhanced by the presence of Matrigel. , 2009, Stem cells and development.

[17]  Gideon Rechavi,et al.  Donor-Derived Brain Tumor Following Neural Stem Cell Transplantation in an Ataxia Telangiectasia Patient , 2009, PLoS medicine.

[18]  Ahmad Y. Sheikh,et al.  Molecular imaging of embryonic stem cell misbehavior and suicide gene ablation. , 2007, Cloning and stem cells.

[19]  R. Perlingeiro,et al.  SSEA-4 identifies mesenchymal stem cells from bone marrow. , 2007, Blood.

[20]  T. Schulz,et al.  The Cell Surface Glycosphingolipids SSEA‐3 and SSEA‐4 Are Not Essential for Human ESC Pluripotency , 2007, Stem cells.

[21]  Zvi Fuks,et al.  Tumor Response to Radiotherapy Regulated by Endothelial Cell Apoptosis , 2003, Science.

[22]  D. Hanahan,et al.  Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors. , 2003, The Journal of clinical investigation.

[23]  S S Gambhir,et al.  Noninvasive optical imaging of firefly luciferase reporter gene expression in skeletal muscles of living mice. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

[24]  D. Solter,et al.  Stage‐specific embryonic antigens (SSEA‐3 and ‐4) are epitopes of a unique globo‐series ganglioside isolated from human teratocarcinoma cells. , 1983, The EMBO journal.

[25]  P. Avner,et al.  Three monoclonal antibodies defining distinct differentiation antigens associated with different high molecular weight polypeptides on the surface of human embryonal carcinoma cells. , 1984, Hybridoma.